CTOs on the Move

paramedics plus

www.paramedicsplus.com

 
paramedics plus is a Tyler, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Evio

Evio is a pharmacy solutions startup that works with health plans to transform the medication experience for everyone: patients, providers, and the system at large.

Axium Healthcare Pharmacy, Inc

Axium Healthcare Pharmacy, Inc. is a nationwide, privately-held Clinical Specialty Pharmacy licensed to operate in all 50 states. Axium Healthcare Pharmacy, Inc.

The Burke Rehabilitation Hospital

The Burke Rehabilitation Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Burke Rehabilitation Hospital is based in White Plains, NY. You can find more information on The Burke Rehabilitation Hospital at www.burke.org

Southcoast Medical Group, P C

Southcoast Medical Group, P C is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Savannah, GA. To find more information about Southcoast Medical Group, P C, please visit www.southcoastmedical.com

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.